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Nerve growth factor (NGF) has been shown to have an effect on neurons in the central 
nervous system (CNS). A number of observations suggest that NGF acts as atrophic 
factor for cholinergic neurons of the basal forebrain and the caudate-putamen. We sought 
to further characterize the CNS actions of NGF by examining its effect on choline ace- 
tyltransferase (CHAT) activity in the cell bodies and fibers of developing neurons of the 
septum and caudate-putamen. ChAT activity was increased after even a single NGF in- 
jection. Interestingly, the magnitude of the effect of multiple NGF injections suggested 
that repeated treatments may augment NGF actions on these neurons. The time-course 
of the response to NGF was followed after a single injection on postnatal day (PD) 2. NGF 
treatment produced long-lasting increases in ChAT activity in septum, hippocampus and 
caudate-putamen. The response in cell body regions (septum, caudate-putamen) was char- 
acterized by an initial lag period of approximately 24 hr, a rapid rise to maximum values, 
a plateau phase and a return to baseline. The response in hippocampus was delayed by 
48 hr relative to that in septum, indicating that NGF actions on ChAT were first registered 
in septal cell bodies. Finally, developmental events were shown to have a regionally spe- 
cific influence on the response of neurons to NGF. For though the septal response to a 
single NGF injection was undiminished well into the third postnatal week, little or no 
response was detected in caudate-putamen at that time. In highlighting the potency and 
regional specificity of NGF effects, these observations provide additional, support for the 
hypothesis that NGF is atrophic factor for CNS cholinergic neurons. 
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INTRODUCTION 
The development  of the nervous system ap- 
pears  to be critically dependent on the presence of 
soluble trophic factors (1, 2). One such factor is 
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nerve growth factor (NGF), a protein molecule 
which has prominent,  well-studied actions on de- 
veloping sensory and sympathetic neurons of the 
peripheral nervous system (3-6). Recent  data in- 
dicate that N G F  also acts on neurons of  the central 
nervous system (CNS). N G F  increases the activity 
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of choline acetyltransferase (CHAT), the synthetic 
enzyme for acetylcholine and a specific marker for 
cholinergic neurons, in immature rat brain tissue in 
vivo and in vitro (7-13). The NGF effect is specific 
for cholinergic neurons and their processes and is 
registered in the septum, nucleus basalis/substantia 
innominata, hippocampus, neocortex and caudate- 
putamen (8, 10, 12). The involvement of these neu- 
rons in processes which attend learning, memory 
(14, 15, 16), and the control of movement (17, 18) 
has encouraged studies of the role played by NGF 
in the central nervous system (CNS). 
Several lines of evidence suggest that NGF 
plays a physiological trophic role in the developing 
CNS. Rodent brain contains messenger RNA 
(mRNA) encoding NGF and the NGF protein (19- 
22). Both NGF and NGF mRNA are enriched in 
areas with dense cholinergic innervation (e.g. hip- 
pocampus and neocortex) (20-22) and the neuro- 
chemical development of basal forebrain choli- 
nergic cell bodies temporally coincides with the 
expression of NGF and its mRNA in these target 
areas (23). Moreover, receptors which are specific 
for NGF have been found in embryonic chick brain 
(24, 25), in the rodent brain on large, presumably 
cholinergic, neurons in the basal forebrain and cau- 
date-putamen (26-28) and in human basal forebrain 
(29). NGF receptor molecules have also been de- 
tected in rodent hippocampus and neocortex (26, 
27). NGF receptors appear to be localized on chol- 
inergic neurites in these target regions for when ra- 
dioactively-labelled NGF was injected into the hip- 
pocampus or cerebral cortex it was transported re- 
trogradely to large basal forebrain neurons (30, 31). 
Finally, in recent experiments in which NGF anti- 
body injections were timed to deprive developing 
neurons of their NGF supply, there were specific, 
long-lasting reductions in ChAT activity in the basal 
forebrain (32). 
Studies of peripheral neurotrophic factors have 
demonstrated the potential importance of develop- 
mental stage in determining the magnitude and na- 
ture of their effects. For example, while fetal bo- 
vine adrenal medullary cells respond to NGF with 
neurite outgrowth and neutrotransmitter enzyme in- 
duction, neurites fail to grow from calf adrenal med- 
ullary cells and neither response is recorded with 
the adrenal medullary cells of adult animals (33). 
Developmental stage is also a critical determinant 
in the nature of the response of sensory and sym- 
pathetic neurons to NGF antibody injections. An- 
tibody injections must be given at the appropriate 
developmental stage to destroy neurons (34). These 
observations suggest that there are stage-specific 
developmental alterations in the function and, per- 
haps, in the mechanism(s) by which NGF acts. 
To further investigate NGF actions on choli- 
nergic neurons of the forebrain, we have examined 
the effects of developmental stage on the ChAT ac- 
tivity response in septum, hippocampus and cau- 
date-putamen. Using a number of injection proto- 
cols, we noted similarities as well as significant 
regional differences in the response of basal fore- 
brain and caudate-putamen neurons to NGF admin- 
istration. Of note, developmental stage had a clear 
effect on the ChAT activity response in the cau- 
udate-putamen during early postnatal development. 
EXPERIMENTAL PROCEDURE 
NGF Preparation. Mouse NGF was prepared and charac- 
terized as described (12, 35). For some experiments, material was 
used which had been further purified by electrofocusing and gel 
filtration (12). 
Animal Preparation and Injection Technique 
Postnatal Animals. Pregnant Spragne-Dawley rats were in- 
dividually housed and kept on a 12 hour daylight cycle. The birth 
of the litters was recorded every 12 hours and the day of birth 
was recorded as postnatal day (PD) 1. For early postnatalinjections 
(i.e., PD2 through 8), a syringe needle (27 gauge; Hamilton) was 
placed approximately 2 mm anterior to the interaural line and 1.5 
mm lateral to the sagittal suture and an intraventricular injection 
was made after direct transcutaneous puncture in restrained un- 
anesthetized pups (10). For PD22 animals, anesthesia was 
achieved with Nembutal (20-25 mg/kg), the scalp was shaved, 
and a linear incision was made in the midline. After scraping the 
surface of the exposed bone, an injection was made with a 27 
gauge needle approximately 2.5 mm lateral to the sagittal suture 
at a point 2 mm anterior to the intersection of the latter with the 
lambdoid suture and at a depth of approximately 3 mm. Blue 
Dextran (Sigma) in phosphate-buffered saline was injected to 
confirm that injected material perfused the entire ventricular sys- 
tem. 
Adult Animals. Intraventricular cannulae were placed in the 
right lateral ventricle in adult male rats (225-250 gm) two to three 
days prior to NGF injection. After anesthesia with IM ketamine 
HC1 (50 mg/kg) and xylazine (10 mg/kg), the animals were pre- 
pared, as above, and a 27 gauge stainless steel cannula was ster- 
otaxically implanted 8.7 mm anterior to the interaural line, 1.5 
mm lateral to the sagittal suture and 4.0 mm deep to the surface 
of the skull. Injections were made via a saline filled PE 20 catheter 
attached to the cannula. Morphological investigation of cannula 
placement indicated that there was no injury to the septum, fim- 
bria-fornix or hippocampus. 
Intracaudate Injection. For intracaudate injection, PD22 an- 
imals were shaved, lightly etherized and transcutaneous puncture 
was made with a 27 gauge syringe. Coordinates for injection were 
established by prior test injections with cresyl violet. Accuracy 
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of injection was established at sacrifice, 48 hr later, by visually 
confirming the location of the injection track. 
NGF Administration. A number of treatment schedules were 
used and these are specified in the text and legends. For either 
intraventricular or intracandate NGF injections, 10 ~xl of phos- 
phate-buffered saline containing 30 fxg of NGF was administered. 
This NGF dose was shown in earlier studies to give large, re- 
producible changes in ChAT activity in basal forebrain neurons 
which were apparent within 48 hr (12). Controls received an equal 
amount of cytochrome c (Sigma), a molecule physiochemicaIly 
similar to NGF which does not have neurotrophic activity, or 
the vehicle alone. After each NGF or control injection in adult 
animals, the catheter was flushed with 4 txl sterile saline and 
resealed by heating the tip. After injections, animals were re- 
turned to their home cages and rat pups were returned to the 
dam for the periods specified. 
Brain Dissection and Enzyme Assay. Animals were killed by 
decapitation, the brains were quickly removed, divided sagittally 
and dissected on a chilled glass plate. The dissected regions in- 
cluded the septum, hippocampus, nucleus basalis/substantia in- 
nominata and caudate-putamen. The septum was dissected by 
disconnecting the hippocampus at the fornix and making two 
knife cuts immediately in front and in back of the septum con- 
tinuing into the basal forebrain (Figure 1). The septum was then 
pinched away using curved forceps. The nucleus basalis/sub- 
stantia innominata region was removed as follows: the rostral 
margin was the knife cut linking the root of the ventricle behind 
the septum to the base of the brain; another knife cut was then 
placed parallel to the first and 1.5 millimeters caudal to it; a piece 
of tissue, 2 mm thick, was removed which extended 1.5 mm dor- 
sally from the base of the brain. To dissect the caudate-putamen, 
thalamic tissue was removed to the level of the internal capsule. 
Caudate-putamen was then taken anterior to the rostral margin 
of the internal capsule. In very young animals this was approx- 
imated by review of surrounding landmarks. To examine the cy- 
tological contents of the dissected areas in early postnatal ani- 
mals, coronal and parasagittal sections were stained with cresyl 
violet. For detailed analyses in somewhat older (PD18-20) ani- 
mals similar sections were prepared for immunocytochemical 
staining using a monoclonal antibody to ChAT (36, 37). Rats were 
perfused intracardially with 20-40 ml of cold saline, then with 
150 ml of a solution containing 2% paraformaldehyde and .05% 
glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, and, finally, 
with 100 ml of 10% sucrose in cold 0.1 M phosphate buffer. The 
brains were removed, blocked, and cryoprotected in 30% sucrose 
in 0.1 M phosphate buffer overnight at 4 ~ Frozen sections (50 
Ixm) were cut on a sliding microtome and submitted to immu- 
nostaining as described (36). Selected sections were counter- 
stained with cresyl violet. 
Brain homogenates were analyzed for the activity of ChAT 
(38) which was determined in relation to the concentration of 
soluble protein (39), as described (10). For measurements in de- 
veloping animals entire litters were used and the overall ratio of 
males to females was approximately equal in the large groups 
used for these experiments. 
RESULTS 
Establishing a Method for Dissecting the Basal 
Forebrain and Caudate-Putamen. Landmarks for 
o o  
Fig. 1. Landmarks used for dissection of the rat brain for assay 
of CHAT. Panel A is a line drawing of a sagittal section through 
the brain of an adult rat; it illustrates the regions dissected. The 
area marked " S "  is the region identified in the text as septum 
and includes cholinergic parikarya in the medial septal nucleus, 
the vertical limb of the diagonal band of Broca and those in the 
most medial portion of the horizontal limb of the diagonal band. 
The method of septal dissection is given in the text. The hip- 
pocampus was separated from the septum at the fornix. The nu- 
cleus basalis/substantia innominata (NB/si) was dissected as de- 
scribed in the text. ChAT positive perikaryaya found in this 
region are shown in panels B and C. Sections from 3 week old 
animals were immunohistochemically stained with a monoclonal 
antibody to CHAT. Panel B shows ChAT positive perikarya in 
the globus pallidus which are considered part of the nucleus bas- 
alis (37). The arrow points to ChAT positive neuronal processes 
and the stars indicate myelinated areas. Also included in the dis- 
section were neurons of the substantia innominata as shown in 
Panel C. Other abbreviations: fx: fornix; ac: anterior commis- 
sure; th: thalamus; cc: corpus callosum; hip: hippocampus; mid: 
midbrain; 4th V: fourth ventricle; gp: globus pallidus; ot: optic 
tract. 
brain dissection are considerably less distinct in the 
first two weeks of life than in the older brain. This 
is in part because myelination highlights important 
features of regional, neuroanatomy. In order to en- 
sure reproducible tissue sampling, a standardized 
dissection protocol was developed (Figure 1). Par- 
ticular care was taken to separate the caudate-pu- 
tamen, which contains a population of cholinergic 
interneurons, from the globus pallidus and substan- 
tia innominata, tissues which contain a separate 
population of cholinergic projection neurons (37). 
Figure 1 demonstrates the dissection landmarks and 
the morphologic characteristics of ChAT containing 
neurons in the globus pallidus and substantia in- 
nominata. As has been described, these basal fore- 
brain cholinergic neurons are rather large and are 
intensely ChAT-immunoreactive. The fibers of 
cholinergic cells located in this, the nucleus basalis/ 
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substantia innominata region, project to neocortex 
and amygdala (37). Cytologic preparations con- 
firmed the location of these neurons in young ani- 
mals and facilitated dissection of caudate-putamen. 
The septum contained cholinergic neurons of the 
medial septal nucleus and the vertical limb of the 
diagonal band of Broca, as well as cells in the most 
medial portion of the horizontal limb of the diagonal 
band. Neurons contained in the septal dissection 
constitute a more ro.stral collection of basal fore- 
brain neurons which project to hippocampus (37); 
the latter was also taken. The dissection protocol 
thus made it possible to look at NGF effects on the 
cell bodies of basal forebrain cholinergic neurons 
and on their axons in target areas, as well as on the 
cell bodies and fibers of the cholinergic interneurons 
of the caudate-putamen. 
Examining NGF Effects During the Develop- 
ment of Septo-Hippocampal Cholinergic Neurons. 
Initial reports of the in vivo response of central chol- 
inergic neurons to NGF in immature rats used a 
series of injections during the early postnatal period 
with sacrifice on either the 8th or the 12th postnatal 
day (8, 10, 12). The neurons of the basal forebrain 
and caudate-putamen undergo major developmental 
changes during early postnatal life. For example, 
ChAT activity in basal forebrain, hippocampus and 
neocortex increases markedly during the first three 
postnatal weeks (23, 40). Injection schedules which 
span wide developmental windows may obscure 
stage-specific developmental alterations in NGF re- 
sponse. In order to further examine NGF effects, 
we investigated the response to an abbreviated 
schedule of doses. 
First, we examined ChAT activity on PD12 fol- 
lowing NGF or control injection on: 1) PD2; 2) PD's 
2 and 4; or 3) PD's 2, 4, and 6. The full schedule of 
4 injections on PD's 2, 4, 6, and 8 elevated ChAT 
activity by 205% in the septum and 87% in the hip- 
pocampus (10, 12) (Figure 2). Neither a single in- 
jection on PD2 alone, nor two injections on PD's 2 
and 4 produced a detectable effect in the septum or 
hippocampus. Though 3 injections (PD's 2, 4, and 
6) produced a 94% rise in the septum, no effect was 
registered in the hippocampus. These data sug- 
gested either that no NGF response was elicited by 
the earlier injections, or that the response to them 
was transient and disappeared by the 12th PD. 
To determine whether the early NGF treat- 
ments had an effect, two abbreviated series of in- 
jections were carried out. Animals were injected on 
PD's 2 and 4 with assay on PD8 or were injected 
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Fig. 2. Stimulation of ChAT activity in the septum and hippo- 
campus by intraventricular injection of NGF on various postnatal 
days. t h e  day of birth of rat pups was recorded as PD1. Litters 
of rat pups were divided into two groups of two to five pups 
which were then submitted to one of several different treatment 
schedules. Horizontal lines describe the effect of each of these 
different schedules on ChAT activity. NGF and control (vehicle- 
injected) groups were injected on the PD(s) indicated by the in- 
verted arrows. For each NGF injection 30 Izg was administered. 
Details of the injection method are given in Experimental Pro- 
cedures. Following the last injection, pups were returned to the 
dam for the period indicated by the dotted lines and the brains 
were dissected and assayed for ChAT activity. The numbers at 
the right indicate the mean percentage increase in ChAT specific 
activity in NGF-injected animals as compared with controls. 
Means only are shown for clarity. SEM's for the groups were 
10% or less of the means. Where there was a mean increase in 
ChAT activity the increase was statistically significant at the P 
< .05 level using Students' t test. 
on PD's 6 and 8 with assay on PD12 (Figure 2). Both 
schedules significantly increased ChAT activity in 
the septum and hippocampus. When expressed as 
percent increase relative to litter mate controls, 
NGF effects were equivalent in these two groups. 
It was noted that no other series of injections 
produced the increases in ChAT activity seen with 
the initial series of four injections. Especially re- 
markable was the apparent discrepancy between the 
effect of 4 injections (PD's 2, 4, 6, and 8) and that 
recorded for two injections given on PD's 6 and 8. 
A comparison shows that there was more than a 
three-fold difference (205% vs. 64%) in the response 
in septum and about 1.8-fold difference (87% vs. 
53%) in the response in hippocampus (Figure 2). 
Since the effect of injections on PD's 2 and 4 alone 
were no longer apparent by PD12 (Figure 2), it is 
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not possible to ascribe the combined effect of 4 in- 
jec t ions  to simple addition of individual ChAT ac- 
tivity responses.  Instead, it appears that the early 
N G F  injections augmented the response to later ad- 
ministration. 
An N G F  effect on ChAT activity in septum was 
present  beyond the early postnatal period. A single 
N G F  injection (30 txg) on PD22 elicited a 69% in- 
crease  in ChAT activity within 48 hr (PD24) (Figure 
4). Indeed,  a significant increase in ChAT activity 
was also registered in the septum of adult animals 
given multiple injections of  NGF.  Given every  other  
day, a series of  4 injections increased ChAT activity 
in the septum of  adult male animals by 36% relative 
to controls  (inject 30 Ixg N G F  every other  day for 
a total of  4 injections with sacrifice 24 hr after the 
last t reatment;  mean + SEM; control  = 125 _+ 8 
nmol acetylcholine formed/h/mg protein [n = 6]; 
N G F  = 170 + 6 [n = 6], 36% increase, P < .01). 
Interestingly,  to date a ChAT activity response 
to N G F  has not been detected in the intact hippo- 
campus beyond the early postnatal period. Whether  
measured  48 or 96 hour's after a single N G F  injection 
at PD22, no response of  hippocampal ChAT activity 
was apparent  (inject 30 Ixg N G F  on PD22 and sac- 
rifice PD26; control  = 90 + 12 [n = 3]; N G F  = 
95 -+ 5 [n = 5]. The multiple N G F  series described 
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Fig. 3. Relationship between the timing of intraventricular in- 
jection of NGF and change in ChAT activity in the caudate-pu- 
tamen of immature rats. Litters of rat pups were divided into two 
groups of two to five animals and submitted to NGF or control 
(vehicle) treatment as outlined in Figure 2. Following the last 
injection, pups were kept with the dam over the period indicated 
by the dotted lines and the caudate-putamen was then dissected 
and assayed for ChAT activity. The mean increase in ChAT spe- 
cific activity in NGF-treated animals is shown by the numbers 
on the right. SEM's were 10% of mean. Mean increases in ChAT 
activity were significant at the P < .05 level. 
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Fig. 4. Regional differences in the ChAT activity response to 
NGF injection during the development of forebrain cholinergic 
neurons. ChAT activity responses to single (30 Ixg) NGF injec- 
tions were determined 48 hr after intraventricular administration. 
NGF-treated and control groups each consisted of 2 to 6 animals. 
Data for NGF-injected animals are given as percent specific ac- 
tivity of control (vehicle-injected) animals. Mean -+ SEM are 
listed over the postnatal day at time of assay. 
for  adult animals also failed to alter hippocampal 
ChAT activity (data not shown). 
Examining NGF Effects in the Developing Cau- 
date-Putamen. Using the same t reatment  protocols ,  
the ChAT activity response to N G F  was also ex- 
amined in the developing caudate-putamen.  Several 
features of  the response were similar to those in 
septum. As was true in septum, injections confined 
to the first postnatal  week were ineffective in in- 
creasing ChAT activity when assayed on PD12. 
Even  3 doses (PD's 2, 4, & 6) failed to produce a 
response (Figure 3). However ,  an N G F  response 
was clearly present  in both of  the two-injection se- 
ries; this indicated that, like septum, the response 
in caudate-putamen was transient. Also, just  as in 
septum, early N G F  doses apparently augmented the 
response to later injections. Comparing the effect 
of 4 injections (PD's 2, 4, 6, & 8) with two (PD's 6 
& 8), the effect in caudate-putamen was somewhat  
less p ronounced  than in septum, amounting to a 2.5- 
fold (134% vs 53%) increase (Figure 3). 
Though similar to septum in these respects,  
there was a significant difference during develop- 
ment in the response of  the caudate-putamen to 
NGF.  While a series of  two injections given on PD's  
2 and 4 increased ChAT activity 178% relative to 
control,  when delivered on PD's  6 and 8 N G F  pro- 
duced only a 53% increase (Figure 3). A decreasing 
responsiveness to exogenous N G F  was equally ap- 
parent  in the relative effectiveness of  a single in- 
ject ion given on PD2 (155% increase) or on PD8 
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(55%) (Figures 3, 4). Thus, there was a significant 
lessening of  the N G F  effect during this period. The 
differing responses in septum and caudate-putamen 
were  even more marked in later developmental  
stages. Though a single injection of  NGF at PD22 
elicited a pronounced  response in septum (see 
above),  a small (15%) and insignificant effect was 
recorded  in the caudate-putamen (Figure 4). To de- 
termine whether  failure of  injected N G F  to pene- 
t rate  caudate-putamen was responsible for the lack 
of  response,  N G F  was given directly into the cau- 
date-putamen in 22 day-old animals. Animals were 
killed 48 hours after  injection and the injection track 
was visually confirmed. These injections of N G F  
had no effect  on ChAT activity (inject 30 Ixg N G F  
on PD22 and assay on PD24; control = 650 _+ 50 
In = 2]; N G F  = 674 _+ 60 In = 3]). The response 
of  caudate-putamen in adult animals was not ex- 
amined. 
Time Course of  NGF Effects in Cell Body and 
Fiber Regions o f  Early Postnatal Animals. To fur- 
ther  examine the ChAT activity responses in septum 
and caudate-putamen,  a single injection of  N G F  was 
given on PD2. There  was no definite effect through 
the first 24 hours (Figure 5). Over the next  24 hours 
there  was a brisk rise in septum (180% of control) 
and caudate-putamen (260%), which was main- 
tained for at least an additional 48 hours. ChAT ac- 
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Fig. 5. Regional rise of ChAT activity in neonatal rat pups after 
a single intraventricular injection of NGF on PD2. Litters of rat 
pups were divided into groups of four or five and a single (30 ~xg) 
injectiori of NGF was given on PD2. Following a specified post- 
injection interval, NGF-treated and control (vehicle-treated) 
groups were taken for assay of ChAT activity in the caudate- 
putamen, septum and hippocampus. The elevation in ChAT spe- 
cific activity in the NGF injected animals is shown as percent of 
control _+ SEM. Due to maturation, the absolute control value 
rose during the period over which these experiments were con- 
ducted. 
tivity returned to control  levels by the PD10. The 
response in both these cholinergic cell-body regions 
was similar with respect  to an initial lag period, a 
rapid rise to maximum values, a plateau phase and 
then a return to baseline. 
The hippocampal response to N G F  was distinct 
from that for  septum. Most  important,  there was a 
clear lag relative to septum in both the ChAT ac- 
tivity increase and its subsequent  decline. While a 
clear increase was present  in the septum 48 hours 
after injection, hippocampus was unchanged at that 
time. Responses  of the magnitude recorded in sep- 
turn were first detected in hippocampus at 96 hours 
after injection and persisted through the 10th PD. 
The temporally distinct responses of septum and 
hippocampus indicated that the N G F  effect on 
ChAT activity was first registered in developing 
cholinergic cell bodies. 
DISCUSSION 
As yet  we know very  little of  the physiological 
principles or mechanisms which underlie neuro- 
trophic interactions in the CNS. Nevertheless ,  cur- 
rent data for  the regional distribution of N GF (20- 
22) and its receptors  (26) in the forebrain suggest 
that it is released in target areas to act on the neu- 
rites of developing and mature cholinergic neurons 
of  the basal forebrain and caudate putamen. The 
present  results demonstra te  distinct regional differ- 
ences in the timing and magnitude of  responses to 
N G F  and document  that striking increases in ChAT 
activity result f rom even a single N G F  injection. In 
highlighting the regional specificity and potency of  
N G F  effects these observations provide additional 
support  for the hypothesis  that N G F  has a t roph i c  
influence on CNS cholinergic neurons in septum 
and caudate-putamen.  
The efforts taken in dissection made it possible 
to examine responses in brain regions containing 
different populations of cholinergic neurons and 
their fibers. Particular care was taken to separate 
the cholinergic neurons in the caudate-putamen 
from those in the basal forebrain found in nucleus 
basalis and substantia innominata. Using the dis- 
section protocol ,  instances were observed in which 
the response of the nucleus basalis/substantia in- 
nominata was entirely different from that of the cau- 
date-putamen. For  example,  following injections of  
N G F  on PD's  2, 4, and 6, ChAT activity at PD12 
was increased by 75% in the nucleus basalis/sub- 
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stantia innominata (M. V. Johnston and W. Mobley, 
unpublished observation), but was unchanged in 
caudate-putamen (Figure 3). On the other hand, in- 
jections of NGF on PD's 2 and 4 produced a large 
increase in ChAT activity by PD8 in the caudate- 
putamen (178%) (Figure 3); the elevation in the nu- 
cleus basalis/substantia innominata was modest 
( + 24%) and similar to the responses recorded in the 
septum and hippocampus (Figure 2). 
By examining responses to single injections it 
has been possible to observe NGF actions during 
relatively discrete periods during development. The 
ChAT activity response to a single dose in early 
postnatal life suggests that NGF is acting to tran- 
siently accelerate cholinergic neurochemical differ- 
entiation. After a single NGF injection on day 2, 
ChAT activity in the hippocampus remained at lev- 
els approximately twice those in littermate controls 
from PD6 to I0 (Figure 5). The normal ontogenetic 
pattern of ChAT specific activity in the hippocam- 
pus during this period demonstrates an extended 
plateau at about 50% of adult activity from seven 
to eleven days of age (40). Therefore, it can be cal- 
culated that a single NGF injection raised ChAT 
activity to near adult levels during this time. It 
would be of interest to determine whether these 
NGF effects are associated with other measures of 
neuronal differentiation. For example, the emer- 
gence of ChAT activity in the developing hippocam- 
pus has been correlated with cholinergic synapse 
formation (40, 41). It is possible that NGF-mediated 
increases in ChAT activity are associated with ac- 
celerated formation of cholinergic hippocampal syn- 
aptic contacts or with earlier onset of synaptic func- 
tion; however, at present there is no proof of this. 
In view of the return of ChAT activity to baseline 
levels after NGF tretment, any effect of exogenous 
NGF on synaptogenesis may also be transient. 
NGF effects were recorded in immature and 
mature septohippocampal cholinergic neurons. Re- 
sponses were recorded as early as PD4 and in adult 
animals. Indeed, when expressed in terms of per- 
cent control, NGF-mediated increases in ChAT ac- 
tivity were as dramatic in PD22 animals as in 
younger ones (Figure 4). NGF effects were thus reg- 
istered in developmental stages which precede the 
neurochemical differentiation of this projection and 
in those which follow the major period of synapse 
formation (42). In demonstrating a response in ma- 
ture septo-hippocampal neurons, these data com- 
bine with measurement of NGF and its mRNA in 
adult hippocampus (20-23) to suggest that NGF 
may play a role in the maintenance of mature basal 
forebrain neurons. The nature of that role is not yet 
known but one corollary to these findings is sug- 
gested by NGF effects on sympathetic neurons. NGF 
injections in adult mice increased neurotransmitter 
enzyme activity in target regions in association with 
increased ramification of peripheral neurite net- 
works (43). These data have been interpreted as re- 
flecting an NGF-stimulated collateral sprouting of 
sympathetic neurites. It was speculated that endog- 
enous NGF may play a similar role in maintaining 
mature sympathetic nerve networks (43). Similar 
events may describe NGF actions in the mature hip- 
pocampus. However,  as noted, no ChAT activity 
response was detected in the hippocampus of NGF- 
treated rats beyond the early postnatal period. This 
disparity in septal and hippocampal responses is 
currently unexplained and suggests that develop- 
mentally determined events differentially influence 
NGF responses in cholinergic cell body and target 
regions. It is noteworthy that a ChAT activity re- 
sponse to NGF was seen in the hippocampus fol- 
lowing transection of some cholinergic afferents (44) 
and that NGF treatment may enhance the sprouting 
of cholinergic fibers under such conditions (45). Yet 
to be determined is the relationship of these effects, 
and of the enhanced survival of lesioned septal chol- 
inergic neurons which attends NGF treatment (46, 
47) to NGF actions in intact, mature animals. 
An unexpected observation in these studies 
was that early exposure to NGF augmented the re- 
sponse to later treatments. This effect was seen for 
both septum and caudate-putamen. In both regions, 
ChAT activity changes at PD12 were greater after 
4 injections than after any shorter series assayed on 
the same day. In fact, when allowance was made 
for the expected fall in ChAT activity after early 
NGF injections, the effect of 4 injections was clearly 
greater than that which would have been achieved 
by simply adding the contributions of both 2-injec- 
tion protocols. Thus, it appeared that early injec- 
tions in the 4-injection protocol in some way altered 
the response of these tissues to later NGF admin- 
istration. Several possibilities can be envisioned to 
explain these results. Earlier injections may have 
induced increased expression of NGF receptors or 
modified the events which transpire between NGF- 
receptor binding and the ChAT activity response. 
Regarding the latter, NGF effects on transcriptional 
or translational controls for ChAT may have 
"primed" cholinergic neurons for later injections. 
Further studies will be required to address the na- 
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ture of the NGF-induced increases in ChAT activ- 
ity. 
NGF effects on cholinergic interneurons in the 
caudate-putamen were similar in many respects to 
those in the basal forebrain. However, there was a 
clear difference in the responses of septum and cau- 
date-putamen to NGF delivered during later devel- 
opmental stages. While septum continued to re- 
spond beyond the third postnatal week, a noticeable 
decline in the caudate-putamen response was al- 
ready apparent by the end of the first postnatal 
week. Thus, a single NGF injection on PD2 was 5 
times more effective than one on PD8 and there was 
little or no response on PD22. Of note, cholinergic 
neurochemical differentiation in caudate-putamen is 
delayed relative to that in the septum and adult lev- 
els of specific acitivity for ChAT are not achieved 
until PD25 (48). Thus, in these studies, a response 
to NGF was only registered in quite immature cau- 
date-putamen neurons. The decreasing response of 
caudate-putamen to a single NGF injection may 
have been due to: (1) altered access of NGF ad- 
ministered via the intraventricular route to the cau- 
date-putamen; (2) a decrease in NGF receptor bind- 
ing, perhaps as a result of fewer NGF receptors; or 
(3) a true change in the response of these cholinergic 
eurons to NGF. Changes in the number of NGF 
receptors do not appear to explain the altered re- 
sponse of caudate-putamen neurons in older ani- 
mals. Indeed, more, not less, high affinity NGF re- 
ceptor binding is present in the caudate-putamen of 
mature animals (48) and this binding has been lo- 
calized to the cell bodies of rather large (22 txM in 
diameter), presumably cholinergic, neurons (26). 
Altered access to administered NGF was also con- 
sidered an unlikely explanation in view of the abrupt 
decrease in response over only 6 postnatal days 
(PD2 versus PD8). Evidence which directly ad- 
dressed this consideration was provided by direct 
NGF injection in the caudate-putamen of PD22 an- 
imals. There was no change in ChAT activity as a 
result of this treatment. This result indicated that 
limited NGF access to caudate-putamen does not 
account for the lack of response. Of course, it is 
possible that exogenous NGF which enters caudate- 
putamen is in some way prevented access to NGF 
receptors on cholinergic neurons. Regional differ- 
ences in the access of exogenous NGF to its recep- 
tor could be responsible for the differential respon- 
siveness of caudate-putamen and septum. 
However, current data do not preclude the possi- 
bility of a true change in the response of caudate- 
putamen neurons to NGF during development. In 
vitro studies may be required to decide this issue. 
Precedents for developmentally specific alterations 
in NGF responses have been described for NGF 
targets in the PNS (5). For example, though bovine 
adrenal medullary cells from fetal animals respond 
to NGF with increased neurotransmitter enzyme ac- 
tivity and neurite outgrowth, both responses are lost 
by adulthood. Moreover, this change occurs in spite 
of the continued presence of NGF receptors (33). 
By reviewing the time-course studies in the 
context of other recent data, we can attempt to fol- 
low NGF action in the days following a single in- 
jection on PD2. CNS receptors which bind NGF 
with high affinity (26) and are physicochemically 
similar to those in the periphery (27) are present in 
early postnatal days (24, 48) and probably mediated 
NGF actions (12). If observations in adult animals 
serve as a guide (30), at least some fraction of NGF 
bound to hippocampal receptors was internalized 
and retrogradely transported to cholinergic cell bod- 
ies. The period which intervened between NGF in- 
jection and the septal response was at least 24 hours; 
from prior data (30) this lag period would allow 
ample time for retrograde transport to bring NGF 
from the hippocampus to septum. The event set in 
motion by internalized NGF molecules are as yet 
undefined. It is also not clear what contribution to 
NGF actions is made by molecules which bind di- 
rectly to septal cell bodies. However, since at PD2- 
4 these cells are just beginning cholinergic neuro- 
chemical differentiation, it is likely that increased 
ChAT activity represented an NGF effect on the 
synthesis of new ChAT enzyme molecules in chol- 
inergic cell bodies. It is probable that newly syn- 
thesized ChAT molecules were then transported an- 
terogradely to hippocampus. The pronounced lag in 
hippocampal ChAT activity relative to septum is 
consistent with this suggestion. A preliminary cal- 
culation of the transport rate of ChAT molecules 
through the axon can be made on the basis of the 
delay between ChAT activity responses in the sep- 
tum and hippocampus. Since the ChAT activity as- 
sayed in the hippocampus reflects the presence of 
ChAT molecules throughout its length, new ChAT 
molecules can be assumed to be distributed around 
the midpoint, or at 4 ram, from the fornix. By sub- 
tracting the time of the septal ChAT activity peak 
from the timing of the initial hippocampal response, 
the velocity of anterograde transport of ChAT mol- 
ecules can be estimated to be 2 mm per day. In 
agreement with earlier estimates for ChAT trans- 
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port in peripheral nerve (49), this result suggests that 
ChAT molecules are moved by slow axoplasmic 
transport. These observations, and those given ear- 
lier, suggest that examination of NGF effects on 
forebrain cholinergic neurons will provide further 
insights regarding the dynamics of NGF action in 
the CNS. 
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